Schteingart, David E.

Hippocampal formation volume, memory dysfunction, and cortisol levels in patients with Cushing's syndrome

Starkman, M. N., Gebarski, S. S., Berent, S., & Schteingart, D. E. (1992) · Biological Psychiatry

Pituitary Gland Disorders and TreatmentsStress Responses and Cortisol

Cited by 840

Decrease in cortisol reverses human hippocampal atrophy following treatment of Cushing’s disease

Starkman, M. N., Giordani, B., Gebarski, S. S., Berent, S., Schork, M. A., & Schteingart, D. E. (1999) · Biological Psychiatry

Pituitary Gland Disorders and TreatmentsStress Responses and Cortisol

Cited by 455

Management of patients with adrenal cancer: recommendations of an international consensus conference

Schteingart, D. E., Doherty, G. M., Gauger, P. G., Giordano, T. J., Hammer, G. D., Korobkin, M., & Worden, F. P. (2005) · Endocrine Related Cancer

Adrenal and Paraganglionic TumorsAdrenal Hormones and Disorders

Cited by 421

Depressed Mood and Other Psychiatric Manifestations of Cushingʼs Syndrome: Relationship to Hormone Levels

Starkman, M. N., Schteingart, D. E., & Schork, A. M. (1981) · Psychosomatic Medicine

Pituitary Gland Disorders and TreatmentsStress Responses and Cortisol

Cited by 289

Safety, tolerability, and pharmacokinetics of the anti-IGF-1R monoclonal antibody figitumumab in patients with refractory adrenocortical carcinoma

Haluska, P., Worden, F., Olmos, D., Yin, D., Schteingart, D., Batzel, G. N., Paccagnella, M. L., de Bono, J. S., Gualberto, A., & Hammer, G. D. (2010) · Cancer Chemotherapy and Pharmacology

Adrenal and Paraganglionic TumorsAdrenal Hormones and Disorders

Cited by 197

Use of [18F]fluorodeoxyglucose positron emission tomography in evaluating locally recurrent and metastatic adrenocortical carcinoma

Mackie, G. C., Shulkin, B. L., Ribeiro, R. C., Worden, F. P., Gauger, P. G., Mody, R. J., Connolly, L. P., Kunter, G., Rodriguez-Galindo, C., Wallis, J. W., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism

Adrenal and Paraganglionic TumorsMedical Imaging Techniques and Applications

Cited by 115

Effects of aminoglutethimide upon adrenal function and cortisol metabolism in Cushing's syndrome

SCHTEINGART, D. E., & CONN, J. W. (1967) · The Journal of Clinical Endocrinology & Metabolism

Adrenal Hormones and DisordersPituitary Gland Disorders and Treatments

Cited by 53

Mebendazole Monotherapy and Long-Term Disease Control in Metastatic Adrenocortical Carcinoma

Dobrosotskaya, I. Y., Hammer, G. D., Schteingart, D. E., Maturen, K. E., & Worden, F. P. (2011) · Endocrine Practice

Adrenal and Paraganglionic TumorsAdrenal Hormones and Disorders

Cited by 53

Overexpression of CXC chemokines by an adrenocortical carcinoma: a novel clinical syndrome

Schteingart, D. E., Giordano, T. J., Benitez, R. S., Burdick, M. D., Starkman, M. N., Arenberg, D. A., & Strieter, R. M. (2001) · The Journal of Clinical Endocrinology & Metabolism

Chemokine receptors and signalingAdrenal and Paraganglionic Tumors

Cited by 45

Comparison of the adrenalytic activity of mitotane and a methylated homolog on normal adrenal cortex and adrenal cortical carcinoma

Schteingart, D. E., Sinsheimer, J. E., Counsell, R. E., Abrams, G. D., McClellan, N., Djanegara, T., Hines, J., Ruangwises, N., Benitez, R., & Wotring, L. L. (1993) · Cancer Chemotherapy and Pharmacology

Adrenal and Paraganglionic TumorsAdrenal Hormones and Disorders

Cited by 38

Adrenal proteins bound by a reactive intermediate of mitotane

Cai, W., Counsell, R. E., Schteingart, D. E., Sinsheimer, J. E., Vaz, A. D. N., & Wotring, L. L. (1997) · Cancer Chemotherapy and Pharmacology

Adrenal and Paraganglionic TumorsAdrenal Hormones and Disorders

Cited by 27